The vaccine, developed in collaboration with the University of Oxford, is one of the most promising among the dozens that researchers around the world seek to be effective and effective.
The purpose is to “start production of the vaccine in the first quarter of next year,” Mexican President Andrés Manuel López Obrador said at a press conference.
He said the vaccine would be “universal and gratuitous” in Mexico, which has recorded nearly 55,000 coronavirus deaths, the third highest number of deaths in the world.
The production will be financed through the base of the Mexican tycoon Carlos Slim.
AstraZeneca’s representative in Mexico, Silvia Varela, said the asset would be manufactured in Argentina and sent to Mexico where the vaccine would be finished for export to the region.
Brazil, which has recorded more than 100,000 coronavirus deaths, has a separate account with the Anglo-Swedish pharmaceutical company.